by | Jun 2, 2022 | Uncategorized
Source: Healio News In this video, Yael Malul, MSN, RN, AGACNP-BC, OCN, discussed presentations on immune effector cell administration best practices and new treatment strategies for multiple myeloma at Oncology Nursing Society Congress 2022.Malul said that it was...
by | Jun 1, 2022 | Uncategorized
Source: ASCO Daily News Dr. Sonali Smith, of University of Chicago Medicine, highlights dynamic sessions and hot topics that will be featured in the 2022 ASCO Annual Meeting Scientific Program, including practice-changing advances in breast cancer, colorectal cancer,...
by | May 27, 2022 | Uncategorized
Source: ASCO Daily News Dr. John Sweetenham, of the UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center, and Dr. Marc Braunstein, of NYU Langone Health, discuss key data from the CAPTIVATE and GRIFFIN trials and other compelling studies in hematologic...
by | May 26, 2022 | Uncategorized
Source: Healio News Although chimeric antigen receptor T-cell therapy is approved for treatment of multiple myeloma, commercially available products are limited to patients who received at least four prior lines of therapy.Given its impressive activity among heavily...
by | May 19, 2022 | Uncategorized
Source: Healio News The addition of isatuximab-irfc to carfilzomib and dexamethasone conferred a durable PFS benefit to patients with relapsed multiple myeloma, according to updated results of the randomized phase 3 IKEMA trial.“These results show an unprecedented...
by | May 18, 2022 | Uncategorized
Source: Cure Today articles The hope, according to an expert, is that this trial will expand CAR-T cell therapy access to more patients with multiple myeloma. Read More
